Betz Stephen F.
SEC insider (Form 3/4/5 filer). CIK 0001886575. Chief Scientific Officer at Crinetics Pharmaceuticals, Inc. (CRNX). 15 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in SAN DIEGO, CA.
Companies Betz Stephen F. has filed insider reports for
- Crinetics Pharmaceuticals, Inc. (CRNX): Officer, Chief Scientific Officer
Betz Stephen F.
CIK: 0001886575
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Crinetics Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect79.7K shares at avg. $85.00$6.8M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect58.3K shares at avg. $85.00$5.0M - Mar 16, 2026CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect4.2K shares at avg. $37.77$160K - Mar 16, 2026CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect6.4K shares at avg. $37.11$236K - Feb 23, 2026CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect30K shares- - Dec 26, 2025CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect18K shares at avg. $1.91$34K - Jun 12, 2025CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect16.6K shares at avg. $9.28$154K - Jun 12, 2025CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect71.5K shares at avg. $1.91$137K - Jun 12, 2025CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect97.5K shares at avg. $32.23$3.1M - Mar 19, 2025CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect291 shares at avg. $34.83$10K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 79,650 | $85.00 | $6,770,250 | Direct |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 58,286 | $85.00 | $4,954,310 | Direct |
| Mar 16, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 4,241 | $37.77 | $160,183 | Direct |
| Mar 16, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 6,371 | $37.11 | $236,428 | Direct |
| Feb 23, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 30,000 | - | $0 | Direct |
| Dec 26, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 18,000 | $1.91 | $34,380 | Direct |
| Jun 12, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 16,645 | $9.28 | $154,466 | Direct |
| Jun 12, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 71,525 | $1.91 | $136,613 | Direct |
| Jun 12, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 97,483 | $32.23 | $3,141,877 | Direct |
| Mar 19, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 291 | $34.83 | $10,136 | Direct |
1-10 of 15 transactions